204 related articles for article (PubMed ID: 19128456)
1. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
Nardinocchi L; Puca R; Sacchi A; Rechavi G; Givol D; D'Orazi G
PLoS One; 2009 Aug; 4(8):e6819. PubMed ID: 19714248
[TBL] [Abstract][Full Text] [Related]
3. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.
Nardinocchi L; Puca R; Givol D; D'Orazi G
Cell Cycle; 2010 Apr; 9(7):1270-5. PubMed ID: 20234185
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.
Nardinocchi L; Puca R; D'Orazi G
Aging (Albany NY); 2011 Jan; 3(1):33-43. PubMed ID: 21248371
[TBL] [Abstract][Full Text] [Related]
6. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
Chen P; Duan X; Li X; Li J; Ba Q; Wang H
Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.
Nardinocchi L; Puca R; Guidolin D; Belloni AS; Bossi G; Michiels C; Sacchi A; Onisto M; D'Orazi G
Biochim Biophys Acta; 2009 Feb; 1793(2):368-77. PubMed ID: 19046997
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia triggers HIPK2 protein degradation.
Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G
Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482
[TBL] [Abstract][Full Text] [Related]
9. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity.
D'Orazi G; Garufi A; Cirone M
IUBMB Life; 2020 Aug; 72(8):1634-1639. PubMed ID: 32593231
[TBL] [Abstract][Full Text] [Related]
11. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
[TBL] [Abstract][Full Text] [Related]
12. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
Li BH; Yuan L; Shi RR; Wang JG
Sheng Li Xue Bao; 2015 Dec; 67(6):611-7. PubMed ID: 26701637
[TBL] [Abstract][Full Text] [Related]
13. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells.
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX
J Exp Clin Cancer Res; 2005 Dec; 24(4):565-74. PubMed ID: 16471319
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
Adamski J; Price A; Dive C; Makin G
PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
[TBL] [Abstract][Full Text] [Related]
15. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
16. CoCl
Rana NK; Singh P; Koch B
Biol Res; 2019 Mar; 52(1):12. PubMed ID: 30876462
[TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.
Puca R; Nardinocchi L; D'Orazi G
J Exp Clin Cancer Res; 2008 Jul; 27(1):22. PubMed ID: 18644116
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation.
Moehlenbrink J; Bitomsky N; Hofmann TG
Cancer Lett; 2010 Jun; 292(1):119-24. PubMed ID: 20018442
[TBL] [Abstract][Full Text] [Related]
20. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]